These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12875794)

  • 41. Ezetimibe--a new cholesterol-lowering drug.
    Drug Ther Bull; 2004 Sep; 42(9):65-7. PubMed ID: 15373326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increasing doses of simvastatin versus combined ezetimibe/simvastatin: effect on circulating endothelial progenitor cells.
    Pesaro AE; Serrano CV; Katz M; Marti L; Fernandes JL; Parra PR; Campos AH
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):447-52. PubMed ID: 23739650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drugs for children with hypercholesterolemia: be cautious.
    Iughetti L
    J Pediatr Endocrinol Metab; 2009 Jun; 22(6):483-5. PubMed ID: 19694194
    [No Abstract]   [Full Text] [Related]  

  • 44. [Target values are more often attainable. Almost doubly so many patients with values under 100mg/dl].
    MMW Fortschr Med; 2004 Oct; 146(44):57. PubMed ID: 15566254
    [No Abstract]   [Full Text] [Related]  

  • 45. Co-administration of ezetimibe and simvastatin in acute myocardial infarction.
    Chenot F; Montant PF; Marcovitch O; Blaimont M; de Meester A; Descamps OS
    Eur J Clin Invest; 2007 May; 37(5):357-63. PubMed ID: 17461981
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ezetimibe/Simvastatin: a review of its use in the management of hypercholesterolemia.
    Murdoch D; Scott LJ
    Am J Cardiovasc Drugs; 2004; 4(6):405-22. PubMed ID: 15554726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of simvastatin-ezetimibe combination therapy on adipose tissue hormones and systemic inflammation in patients with isolated hypercholesterolemia.
    Krysiak R; Zmuda W; Okopien B
    Cardiovasc Ther; 2014 Apr; 32(2):40-6. PubMed ID: 24354929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
    Pearson TA; Denke MA; McBride PE; Battisti WP; Brady WE; Palmisano J
    Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced hypercholesterolemia therapy: the ezetimibe/simvastatin tablet.
    Cole P; Rabasseda X
    Drugs Today (Barc); 2005 May; 41(5):317-27. PubMed ID: 16082429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia.
    Kerzner B; Corbelli J; Sharp S; Lipka LJ; Melani L; LeBeaut A; Suresh R; Mukhopadhyay P; Veltri EP;
    Am J Cardiol; 2003 Feb; 91(4):418-24. PubMed ID: 12586255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia.
    Kastelein JJ; Sankatsing RR
    Int J Clin Pract; 2005 Dec; 59(12):1464-71. PubMed ID: 16351680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers.
    Efrati S; Averbukh M; Dishy V; Faygenzo M; Friedensohn L; Golik A
    Eur J Clin Pharmacol; 2007 Feb; 63(2):113-21. PubMed ID: 17200833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale.
    Inazawa T; Sakamoto K; Kohro T; Iijima R; Kitazawa T; Hirano T; Kawamura M; Tagami M; Tanaka A; Mori Y; Yamazaki T; Shiba T;
    Lipids Health Dis; 2013 Oct; 12():142. PubMed ID: 24094079
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ezetimibe combines with simvastatin to tackle cholesterol. New drugs attack "bad" cholesterol in the liver and intestine.
    Heart Advis; 2007 Jul; 10(7):7. PubMed ID: 17695657
    [No Abstract]   [Full Text] [Related]  

  • 55. Ezetimibe and low density lipoprotein subfractions: an ongoing debate.
    Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
    Curr Med Res Opin; 2011 Mar; 27(3):693-5. PubMed ID: 21275848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?
    Brown BG; Taylor AJ
    N Engl J Med; 2008 Apr; 358(14):1504-7. PubMed ID: 18376002
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapy of familial hypercholesterolemia with or without ezetimibe].
    Berthold HK; Nitschmann S
    Internist (Berl); 2008 Oct; 49(10):1274-6. PubMed ID: 18754087
    [No Abstract]   [Full Text] [Related]  

  • 58. Getting there: statin plus ezetimibe for low-density lipoprotein cholesterol goals.
    Hurley DL; Isley WL
    Mayo Clin Proc; 2005 May; 80(5):585-6. PubMed ID: 15887424
    [No Abstract]   [Full Text] [Related]  

  • 59. The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome.
    Jimenez JG; Rosen JB; Pirags V; Massaad R; Hanson ME; Brudi P; Triscari J
    Diabetes Obes Metab; 2013 Jun; 15(6):513-22. PubMed ID: 23279632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.